These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35957887)

  • 1. Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling
    Li Y; Xu C; Sun B; Zhong F; Cao M; Yang L
    Front Oncol; 2022; 12():913498. PubMed ID: 35957887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c.
    Li YM; Xu C; Sun B; Zhong FJ; Cao M; Yang LY
    Cancer Cell Int; 2022 Apr; 22(1):162. PubMed ID: 35461277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis.
    Dian MJ; Li J; Zhang XL; Li ZJ; Zhou Y; Zhou W; Zhong QL; Pang WQ; Lin XL; Liu T; Liu YA; Li YL; Han LX; Zhao WT; Jia JS; Xiao SJ; Xiao D; Xia JW; Hao WC
    J Cancer; 2021; 12(15):4463-4477. PubMed ID: 34149910
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin-cholesterol acyltransferase is a potential tumor suppressor and predictive marker for hepatocellular carcinoma metastasis.
    Li Y; Jiang LN; Zhao BK; Li ML; Jiang YY; Liu YS; Liu SH; Zhu L; Ye X; Zhao JM
    World J Gastrointest Oncol; 2024 Aug; 16(8):3651-3671. PubMed ID: 39171187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
    Zhang N; Zhou J; Zhou Y; Guan F
    Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
    Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
    Liu Z; Chen M; Xie LK; Liu T; Zou ZW; Li Y; Chen P; Peng X; Ma C; Zhang WJ; Li PD
    Aging (Albany NY); 2018 Oct; 10(10):2570-2584. PubMed ID: 30312171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
    Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
    Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway.
    Tian K; Deng Y; Li Z; Zhou H; Yao H
    Oncol Lett; 2024 Jan; 27(1):18. PubMed ID: 38034486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway.
    Huang L; Yang Q; Chen H; Wang Z; Liu Q; Ai S
    Open Med (Wars); 2022; 17(1):626-637. PubMed ID: 35434373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway.
    Wang Y; Fang X; Xie H; Wang X
    Biochem Genet; 2024 May; ():. PubMed ID: 38789846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling Pathway.
    Huang K; Lin Y; Wang K; Shen J; Wei D
    J Hepatocell Carcinoma; 2022; 9():1323-1339. PubMed ID: 36573219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.